Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
PUT
Unum
UNM
$14.8B
| $5.48M | ﹤0.01% |
161,100
-30,100
| -16% | -$1.02M |
|
3527
CALL
MarketAxess Holdings
MKTX
$5.72B
| $5.48M | ﹤0.01% |
21,400
-11,500
| -35% | -$3.15M |
|
3528
Guardant Health
GH
$21.1B
| $5.48M | ﹤0.01% |
135,802
-398,623
| -75% | -$19.8M |
|
3529
CenterPoint Energy
CNP
$26.9B
| $5.48M | ﹤0.01% |
185,169
-356,494
| -66% | -$11M |
|
3530
Applied Industrial Technologies
AIT
$13.3B
| $5.47M | ﹤0.01% |
56,894
+30,855
| +118% | +$3.12M |
|
3531
Cencora
COR
$59.9B
| $5.47M | ﹤0.01% |
38,656
+25,598
| +196% | +$3.92M |
|
3532
Goldman Sachs MarketBeta Emerging Markets Equity ETF
GSEE
$137M
| $5.47M | ﹤0.01% |
131,314
+122,834
| +1,449% | +$5.34M |
|
|
VIGL
3533
DELISTED
Vigil Neuroscience
VIGL
| $5.47M | ﹤0.01% |
2,165,036
+2,397
| +0.1% | +$9.47K |
|
|
ETRN
3534
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $5.47M | ﹤0.01% |
859,423
+463,072
| +117% | +$3.57M |
|
3535
CALL
dLocal
DLO
$4.17B
| $5.46M | ﹤0.01% |
+208,200
| New | +$5.33M |
|
3536
PUT
iShares MSCI Germany ETF
EWG
$1.68B
| $5.46M | ﹤0.01% |
237,400
+103,500
| +77% | +$2.7M |
|
3537
Sunstone Hotel Investors
SHO
$2.03B
| $5.46M | ﹤0.01% |
550,279
-4,073,465
| -88% | -$46.6M |
|
|
XM
3538
PUT
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $5.46M | ﹤0.01% |
436,200
+188,200
| +76% | +$3.35M |
|
|
CLRM
3539
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
| $5.46M | ﹤0.01% |
555,712
-499,993
| -47% | -$4.9M |
|
3540
Virgin Galactic
SPCE
$503M
| $5.45M | ﹤0.01% |
45,297
+12,172
| +37% | +$1.77M |
|
3541
Vanguard Consumer Discretionary ETF
VCR
$6.11B
| $5.45M | ﹤0.01% |
23,953
+17,916
| +297% | +$4.68M |
|
3542
PUT
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $5.45M | ﹤0.01% |
204,400
+117,700
| +136% | +$3.31M |
|
3543
PUT
McCormick & Company Non-Voting
MKC
$14.7B
| $5.45M | ﹤0.01% |
65,400
-2,500
| -4% | -$237K |
|
3544
PUT
Hartford Financial Services
HIG
$37.8B
| $5.44M | ﹤0.01% |
83,200
+28,100
| +51% | +$1.97M |
|
3545
CALL
Procore
PCOR
$9.09B
| $5.44M | ﹤0.01% |
119,800
+14,200
| +13% | +$697K |
|
3546
Regeneron Pharmaceuticals
REGN
$82.7B
| $5.43M | ﹤0.01% |
9,194
-8,803
| -49% | -$5.72M |
|
3547
Skywest
SKYW
$4.18B
| $5.43M | ﹤0.01% |
255,702
+88,031
| +53% | +$2.31M |
|
3548
SI-BONE Inc
SIBN
$848M
| $5.43M | ﹤0.01% |
411,367
+162,582
| +65% | +$2.71M |
|
3549
PUT
Owens Corning
OC
$12.2B
| $5.42M | ﹤0.01% |
73,000
+5,700
| +8% | +$503K |
|
3550
CALL
Nexstar Media Group
NXST
$5.84B
| $5.42M | ﹤0.01% |
33,300
-28,700
| -46% | -$4.85M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.